Author(s): Adhikari Anjan | Biswas Sharmistha | Maity Tamoghna | De Radharaman | Debnath Pratip Kumar
Journal: International Journal of Research in Ayurveda and Pharmacy
ISSN 2229-3566
Volume: 2;
Issue: 4;
Start page: 1294;
Date: 2011;
VIEW PDF
DOWNLOAD PDF 
Original page
Keywords: Muvease | Boswellia serrata | Clinical trial | Placebo.
ABSTRACT
Joint and back pain is a common problem throughout the world. Indian population were also suffering from this disorder. Aetiology of this disease is varied & therapeutic remedy in modern medicine is not enough. Not only that, the side effects of the existing medicine are causing deterioration of quality of life. A randomized double-blind placebo controlled clinical study was conducted to evaluate the efficacy, safety and tolerability of Muvease, a herbal formulation, in the management of joint pain, back pain and lumbago. Thirty patients of either sex in the age group of 55- 70 years with clinical and radiological evidence of arthritis were selected for the trial, and treated with Muvease and a placebo tablet. The study design was cross over type with intervention. Evaluation of pre and post interventional results showed significant improvement in the status of the patients treated with muvease.
Journal: International Journal of Research in Ayurveda and Pharmacy
ISSN 2229-3566
Volume: 2;
Issue: 4;
Start page: 1294;
Date: 2011;
VIEW PDF
DOWNLOAD PDF Original pageKeywords: Muvease | Boswellia serrata | Clinical trial | Placebo.
ABSTRACT
Joint and back pain is a common problem throughout the world. Indian population were also suffering from this disorder. Aetiology of this disease is varied & therapeutic remedy in modern medicine is not enough. Not only that, the side effects of the existing medicine are causing deterioration of quality of life. A randomized double-blind placebo controlled clinical study was conducted to evaluate the efficacy, safety and tolerability of Muvease, a herbal formulation, in the management of joint pain, back pain and lumbago. Thirty patients of either sex in the age group of 55- 70 years with clinical and radiological evidence of arthritis were selected for the trial, and treated with Muvease and a placebo tablet. The study design was cross over type with intervention. Evaluation of pre and post interventional results showed significant improvement in the status of the patients treated with muvease.
